جست‌وجوی استاد و پژوهشگر

Ryan Sengerمشاهده پروفایل

دانشیار

• Metabolic Engineering
• Synthetic Biology
• Systems Biology
• +۵ مورد دیگر

Ryan Senger serves as Associate Professor in the Department of Biological Systems Engineering at Virginia Tech's College of Engineering, with courtesy appointments in Chemical Engineering (Virginia Tech) and Surgery (Virginia Commonwealth University School of Medicine). His research bridges metabolic engineering, synthetic biology, and biomedical diagnostics through innovative applications of Raman spectroscopy. Education: Ph.D., Chemical Engineering, Colorado State University, 2005 M.S., Chemical Engineering, Colorado State University, 2002 B.S., Chemistry, Millikin University, 1999 Senger's research focuses on developing bio-based technologies for sustainable chemical production, disease detection through urine analysis, and synthetic biology containment. His lab pioneers Raman spectroscopy-based chemometric urinalysis (Rametrix) for detecting diseases including bladder cancer, chronic kidney disease, Lyme disease, and Long COVID. Current projects involve bioelectrical system engineering in microbes, electron harvesting from waste biomass, and secure synthetic genetic material containment. His work integrates AI/ML for spectral analysis and genome-scale metabolic modeling. His recent publications demonstrate strong trends in veterinary diagnostics (canine cancer detection), neurological disease monitoring, and renal dysfunction profiling using Raman chemometrics. The research consistently applies spectral fingerprinting to translate complex biological data into clinical diagnostic tools. Awards: 2022-24: Celebrating Innovation Recognition (x4) 2023: Dean’s List of Instructors 2016: VT Knowledgeworks Innovation Challenge Winner 2009: The Gaden Award for Metabolic Engineering Senger actively mentors students through laboratory research and teaches courses including Thermodynamics of Biological Systems, Metabolic Engineering, and Bio-Raman Chemometrics. His funding portfolio includes NSF grants for metabolic modeling workshops and commercial projects with Rametrix Technologies (where he serves as CTO), focusing on dialysis patient monitoring, renal disease management, and aquaculture feed development. He directs the Rametrix Technologies research team that develops urine-based diagnostic devices and spectral analysis software, maintaining strong industry-academic partnerships for technology commercialization.

• Statistics
• Probability
• Machine Learning
• +۶ مورد دیگر

Feng Yu is a Senior Lecturer in Statistics at the School of Mathematics, University of Bristol, focusing on probability and statistical methods. Research interests include Bayesian inference, statistical hypothesis testing, machine learning applications in medical research, and interdisciplinary work with biomedical engineering. Key contributions involve developing methods for multiple comparison procedures, dose-finding trials, and 3D printing parameter optimization using AI. Recent publications highlight trends in integrating statistical rigor with biomedical innovation, spanning clinical trials, dose-finding studies, and additive manufacturing for bone scaffolds and implants. Collaborations include work on hybrid systems for tissue regeneration. Projects include "Girsanov Transformation and the Rate of Adaptation" (2011-2013), exploring probabilistic models in evolutionary biology. Affiliations are centered on the University of Bristol, with no scientific awards mentioned.

• Meniscus and Cartilage Biology
• Molecular Mechanisms of Regeneration and Repair
• Translational Models of Musculoskeletal Disease

Liane Miller, MD serves as an Assistant Professor of Orthopaedic Surgery at the Perelman School of Medicine, University of Pennsylvania, specializing in sports medicine with clinical focus on complex knee, shoulder, and hip pathologies including ligament reconstructions, meniscus repairs, and cartilage restoration procedures. Her educational background includes: B.S. in Cellular and Developmental Biology, University of California, Santa Barbara (2008) M.D. in Medicine, University of California, San Francisco School of Medicine (2016) Dr. Miller's research program centers on Meniscus and Cartilage Biology , Molecular Mechanisms of Regeneration and Repair , and Translational Models of Musculoskeletal Disease , employing both basic science and clinical approaches to enhance tissue healing. Her laboratory investigates cellular responses to injury and novel regenerative pathways with direct surgical applications. Analysis of her 15 most recent publications (2023-2025) reveals dominant themes in sports medicine: knee ligament reconstruction optimization, shoulder instability management, and meniscal repair techniques. She demonstrates particular expertise in arthroscopic procedures and has developed clinical tools like the PIVOT App for surgical planning, bridging biomechanical research with patient outcomes. Scientific awards: No awards documented in source materials Dr. Miller mentors medical students and orthopaedic residents in clinical settings, though specific advisees weren't listed. Her research receives institutional support at Penn but lacks details on external grant funding. She actively contributes to the academic mission through surgical innovation and evidence-based practice development. Her clinical work integrates seamlessly with the University of Pennsylvania's sports medicine division, where she participates in multidisciplinary teams managing complex musculoskeletal cases from diagnosis through rehabilitation.

• Bioprocess Engineering
• Downstream Processing
• Biopharmaceuticals
• +۴ مورد دیگر

Prof. Dr. Michel H.M. Eppink is a Special Professor in “Industrial Biopharmaceutical Downstream Processing” at the Department of Biotechnology, Faculty of Applied Sciences, Delft University of Technology. With over 35 years of experience in biomolecule processing, he brings extensive industry expertise from Organon NV and Byondis BV to his academic role. His current position is part-time (0.2 FTE), focusing on integrating harvesting, cell disruption, extraction, separation and formulation technologies for biopharmaceuticals. His research interests include developing lean production processes for biopharmaceuticals with emphasis on green technologies, circular economy principles, and cost reduction in medicine production. He specifically investigates fractionation technologies and process integration for biopharmaceutical proteins including monoclonal antibodies and antibody-drug conjugates. His work addresses bottlenecks in process robustness, efficiency, product quality, and waste reduction. Prof. Eppink has received his MSc in Biology/Chemistry from Utrecht University (1993) and PhD in Biochemistry from Wageningen University (1999). Before joining TU Delft in 2024, he served as part-time Professor at Wageningen University from 2014-2024, leading research on biorefinery technologies for proteins, lipids, carbohydrates and pigments from various eukaryotic organisms. His recent publications focus on chromatography optimization and digital twin applications in biopharmaceutical process development, reflecting his expertise in improving efficiency and sustainability in biomanufacturing processes. These works demonstrate trends toward continuous processing, high-throughput screening, and data-driven optimization in downstream biopharmaceutical production. Prof. Eppink actively contributes to education through advanced courses in Bioprocess Design and Downstream Processing at the Biotechnology Academy Delft, as well as lectures at Wageningen University, Leiden University, Utrecht University, Karlsruhe Institute of Technology, Radboud University, and Maastricht University. His office is located in Building 58, room C2.150 at TU Delft, and he can be reached at M.H.M.Eppink@tudelft.nl or +31 683169622.

Pamela Peralta-Yahyaمشاهده پروفایل

استاد

• Synthetic Biology
• Chemical Biology
• Organic Chemistry
• +۵ مورد دیگر

Pamela Peralta-Yahya is a Professor and Associate Chair for Research and Postdoctoral Training at the Georgia Institute of Technology, affiliated with the School of Chemistry and Biochemistry and the School of Chemical & Biomolecular Engineering. Her research integrates biochemistry and chemical engineering to develop innovative solutions for chemical detection and sustainable bioproduction. BA, Macalester College, 2003 Ph.D., Columbia University, 2008 Postdoc, University of California, Berkeley & Lawrence Berkeley National Laboratory, 2008-2011 Her work focuses on engineering G protein-coupled receptors (GPCRs) for biomedical and biotechnology applications, particularly olfactory receptors, and designing biological systems for renewable fuel and chemical synthesis. Key projects include standardizing GPCR sensors in yeast to expedite drug discovery and creating advanced biofuels like pinene for aerospace applications. Current funding from NIH, NSF, DOE, and NASA supports cutting-edge research on Martian rocket fuel and synthetic cellular learning mechanisms. Her lab’s publications highlight advancements in GPCR-based sensing, carbon-negative amino acid synthesis, and microbial engineering for sustainable polymers. The group also explores carbon-conserving bioproduction and the use of cell-free systems for efficient chemical synthesis. 2022 Vasser Woolley Faculty Fellowship 2022 Cullen Peck Scholar Award 2017 NIH Maximizing Investigators' Research Award 2016 Samsung GRO Competition 2016 Kavli Fellowship 2015 Blanchard Fellowship 2014 DARPA Young Faculty Award 2014 DuPont Young Professor for Scientific Innovation Award The Peralta-Yahya lab actively recruits students from the BioEngineering, Bioinformatics, and Paper Science & Engineering programs at Georgia Tech. Their research bridges fundamental biochemical principles with practical applications in energy, health, and environmental sustainability.

Ahmed Badranمشاهده پروفایل

استادیار

• Synthetic Biology
• Molecular Evolution
• Biochemistry
• +۳ مورد دیگر

Ahmed Badran is an Assistant Professor at the Scripps Research Institute , specializing in Synthetic Biology and Molecular Evolution . Previously, he was affiliated with the Liu Lab at the Department of Chemistry and Chemical Biology at Harvard University during his doctoral studies (enrolled 2010). Research Focus: Designing artificial enzymes for sustainable biomanufacturing, combating antibiotic resistance, and developing precision therapeutics through synthetic biology strategies. Publications: Recent work includes studies on precision antibiotics and tRNA-directed evolution of quadruplet codon suppression systems. Labs: Leads the Badran Lab at Scripps Research Institute, dedicated to innovative solutions in biotechnology and medicine.

Vincent Noireauxمشاهده پروفایل

استاد

• Synthetic Biology
• Biological Physics
• Cell-free Systems
• +۳ مورد دیگر

Vincent Noireaux is a Professor at the School of Physics and Astronomy at the University of Minnesota, Twin Cities. His research bridges biological physics and synthetic biology to develop cell-free transcription-translation systems and synthetic cell platforms . Current projects funded by the National Science Foundation and Department of Energy Collaborates with institutions in Israel, Romania, and Washington Expertise: Synthetic biology , cell-free systems , genetic circuits Research Focus : Develops quantitative models for in vitro gene expression and constructs synthetic cells using self-assembling systems . Key areas include biophysics , bioengineering , and biomanufacturing . Email: noireaux@umn.edu

• Biological Process Engineering
• Photosynthetic Microorganism Cultivation
• Reactor Design
• +۳ مورد دیگر

Dr. Guillaume Cogne serves as Senior Lecturer at University of Nantes within the GEPEA laboratory (UMR CNRS 6144), a joint research unit specializing in Process Engineering, Environment, and Agri-food systems. Affiliated with the BAM team at CRTT Saint Nazaire since 2005, his work bridges academic research and industrial applications in sustainable bioprocessing. His educational trajectory includes: Biological Engineering degree from Polytech'Clermont-Ferrand (CUST), 1999 Doctorate from Blaise Pascal University (2003) with thesis at Laboratory of Chemical and Biochemical Engineering (LGCB) Dr. Cogne's research pioneers advanced modeling of photosynthetic microorganism cultivation , focusing on light energy distribution , mass transfer phenomena , and metabolic flux analysis in photobioreactors. His work drives innovations in bioreactor design for optimized biomass production, with significant implications for renewable energy and sustainable biomanufacturing. The interdisciplinary nature of his research integrates chemical engineering principles with biological systems analysis to address global challenges in resource efficiency. As core member of GEPEA's BAM team, he contributes to France's strategic research in environmental bioprocesses through national projects like CPER IG-Pro-BE and TRANSFEE. His laboratory maintains strong industry partnerships focused on translating fundamental research into scalable bioproduction technologies.

Dibakar Bhattacharyyaمشاهده پروفایل

استاد

• Membrane Science & Technology
• Water Treatment & Purification
• PFAS Detoxification
• +۵ مورد دیگر

Dibakar Bhattacharyya—known globally as "DB"—is the University Alumni Professor in the Department of Chemical Engineering and Director of the Center of Membrane Sciences at the University of Kentucky’s Stanley and Karen Pigman College of Engineering. Celebrating 50 years of service in 2017, he remains an internationally recognized leader in membrane science and water technologies. Education: Ph.D. Environmental Engineering, Illinois Institute of Technology, USA, 1966 M.S. Chemical Engineering, Northwestern University, USA, 1963 B.S. Chemical Engineering, Jadavpur University, India, 1962 Research Focus: DB’s group pioneers tunable membranes and biocatalytic systems for next-generation water treatment. Major thrusts include high-performance graphene-oxide and amine-functionalized membranes for PFAS detoxification, selective capture of noble metals from electronic-waste streams, and advanced micro/ultrafiltration platforms that clarify viral vectors for gene-therapy applications. Integration of catalytic layers with membrane pores enables simultaneous separation and reaction, pushing the boundary of reactive membrane filtration . His recent works (2022-25) exhibit a clear trend: multifunctional membranes engineered at the nanoscale to solve emerging environmental and biomedical challenges. PFAS remediation, viral-vector purification, and dual-use air/water cleaning filters dominate the portfolio, often coupled with techno-economic or CFD analyses to speed deployment. Current & Recent Support: Investigations are backed by NSF EPSCoR, NIEHS, NSF EAGER, Australian Research Council, Southern Co. and Chevron, among others, reflecting strong federal & industry confidence. Campus Leadership: DB co-chaired the 2018 North American Membrane Society Annual Meeting, bringing 400+ global experts to Kentucky, and continues to direct the interdisciplinary Center of Membrane Sciences.

Thomas Michael Frimurerمشاهده پروفایل

دانشیار

• Structural biology
• Molecular modeling of alternative functional states
• Design of pharmacological tool compounds
• +۵ مورد دیگر

Thomas Michael Frimurer is an Associate Professor and group leader at The Novo Nordisk Foundation Centre for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Health and Medical Sciences, University of Copenhagen. He leads research in Chemical and Molecular Receptology with a focus on computational approaches to drug discovery. Dr. Frimurer earned his Ph.D. in Computational Structural Biology from the University of Copenhagen in 2000, following an M.S. in Mathematics and Physics from the same institution in 1996. His academic journey included a postdoc at Harvard University (2001-2002) and another at Novo Nordisk A/S (2000), as well as research experience at the Centre for Biological Sequence Analysis at DTU (2000). His research focuses on developing advanced technologies for structure-based drug discovery and optimization, particularly for G protein-coupled receptors (GPCRs). Dr. Frimurer's group specializes in modeling alternative functional states of structurally uncharacterized proteins and 7TM receptors, with the goal of understanding molecular mechanisms of activation and inactivation. He developed the "Site Directed Drug Discovery" (SD3™) platform, which has been applied in numerous drug discovery programs targeting metabolic disorders, obesity, inflammation, and pain. His current work includes developing potent, selective ligands for orphan GPCRs associated with obesity and type-2 diabetes. Analysis of Dr. Frimurer's recent publications (2022-2025) reveals a strong focus on GPCR structure and function, particularly tachykinin receptors, succinate receptor (GPR91), and other metabolite-sensing receptors. His research combines computational approaches with experimental validation to understand receptor activation mechanisms, ligand binding pathways, and signaling bias. The work spans structural biology, molecular dynamics, and translational applications for metabolic diseases. Dr. Frimurer is the author or co-author of over 40 peer-reviewed publications and more than 15 patents related to chemical leads and drug candidates for obesity, type-2 diabetes, asthma, inflammation, and pain. His most recent patent (March 2014) covers oral available small molecule GPR39 agonists as potential treatments for obesity and type-2 diabetes. As a group leader, Dr. Frimurer mentors researchers in computational chemistry and drug discovery. He has been involved in innovation and commercialization activities, including co-founding Ankrin Theapeutics, a company developing cancer therapies. His work has involved collaborations with biotech and pharmaceutical companies, as well as academic institutions, focusing on structure-based approaches to drug discovery. Dr. Frimurer leads a research group focused on Chemical and Molecular Receptology within the Novo Nordisk Foundation Centre for Basic Metabolic Research. His team applies integrated computational approaches to study GPCRs and develop pharmacological tools for understanding metabolic physiology. The group works closely with the Roden Metabolic Phenotyping Center and the Section for Receptology and Enteroendocrinology at the University of Copenhagen.

• Geomechanics
• Oilfield chemistry
• Multiphase fluid dynamics
• +۷ مورد دیگر

Dr. Gbenga Oluyemi is a Professor in the School of Computing, Engineering & Technology at Robert Gordon University (RGU), Aberdeen, UK. His academic work spans petroleum engineering with a growing emphasis on sustainable energy solutions. His research interests encompass Geomechanics, Oilfield chemistry, Multiphase fluid dynamics, Sand prediction and production, Reservoir characterisation , and Formation evaluation . Recent work has expanded into sustainable energy applications including hydrogen storage and carbon capture technologies. Dr. Oluyemi's publication record shows a clear evolution from traditional petroleum engineering topics toward sustainable energy solutions. His recent work integrates machine learning techniques with conventional petroleum engineering challenges, particularly in well integrity management and artificial lift optimization. The research demonstrates strong industry relevance with numerous projects addressing practical challenges in the energy sector. As a supervisor, Dr. Oluyemi has guided multiple PhD students through completion, with thesis topics ranging from marginal field development optimization to geomechanical impacts of oilfield chemicals. His supervision record reflects both technical depth and relevance to current industry challenges. His current projects demonstrate a strategic shift toward sustainable energy applications while maintaining core petroleum engineering expertise, particularly in areas of waste-to-energy conversion and sustainable well abandonment practices.

Sivanadane Mandjinyمشاهده پروفایل

استاد

• Bioprocessing
• Bioseparations
• Biomanufacturing
• +۵ مورد دیگر

Sivanadane Mandjiny serves as Professor and Director of the Biotechnology Research and Training Center at COMTECH, University of North Carolina at Pembroke, operating from the Oxendine Science Building. His dual role integrates academic leadership with hands-on biomanufacturing workforce development. Research centers on industrial bioprocessing optimization, particularly using green fluorescent protein (GFP) as a model system. His work spans upstream processing (cell line identification, fermentation) and downstream processing (centrifugation, filtration, chromatography), with specialized focus on ion exchange chromatography. Key investigations compare protein binding capacities of nylon/PVA membranes versus Sepharose/silica gel beads to generate industry-applicable adsorption data. Students receive intensive training in laboratory techniques and Cytiva Chromatographic systems, preparing them for immediate industry contribution. The program successfully trains career-changers with no prior biomanufacturing background, demonstrating strong industry alignment. The Biotechnology Research and Training Center functions as both research hub and workforce pipeline, directly addressing pharmaceutical sector skill requirements through practical, industry-tested protocols.

Jorge Isaac Chairez-Oriaمشاهده پروفایل

دانشیار

• Biomedical Engineering
• Neural Networks
• Robotic Control Systems
• +۴ مورد دیگر

Jorge Isaac Chairez-Oria is an Associate Professor in the Department of Biomedical Engineering at Tecnológico de Monterrey's School of Engineering, Campus Guadalajara. He maintains an active research program bridging biomedical engineering, neural networks, and robotic control systems with significant contributions to rehabilitation technology and sustainable manufacturing. His research focuses on neural network applications for system identification and control , particularly in constrained dynamical systems. His work spans medical rehabilitation robotics (including exoskeletons and orthotic devices), bioprinting and tissue engineering , and sustainable environmental technologies utilizing neural network approaches. Recent publications demonstrate strong interdisciplinary work connecting engineering principles with biological and medical applications. Analysis of his 2024-2025 publications reveals consistent focus on barrier Lyapunov functions, constrained state systems, and neural network identification methods applied across diverse domains from wastewater treatment to surgical robotics. His work shows particular strength in translating theoretical control concepts into practical biomedical applications. Scientific Recognition: Mexican Researcher Certification - Level 2 Dr. Chairez-Oria teaches courses in Biofluid Mechanics, Clinical Engineering, and Bioinstrumentation Systems design, integrating his research expertise into the classroom. His work aligns with multiple UN Sustainable Development Goals including Good Health and Well-being, Industry Innovation, and Clean Water and Sanitation.

• Animal cell culture engineering
• Therapeutic protein production
• Viral vector production for gene therapy
• +۵ مورد دیگر

Professor Gyun Min Lee is a faculty member in the Department of Biological Sciences at Korea Advanced Institute of Science and Technology (KAIST), where he leads the Animal Cell Engineering Lab. His research focuses on developing advanced mammalian cell systems for therapeutic protein and viral vector production through innovative engineering approaches. Dr. Lee earned his Ph.D. in Chemical Engineering from the University of Michigan, providing him with a strong foundation at the intersection of engineering principles and biological systems. His technical expertise spans from molecular biology to bioprocess engineering, enabling comprehensive solutions for biopharmaceutical production challenges. Professor Lee's research program centers on animal cell engineering for biopharmaceutical applications. His team utilizes synthetic biology approaches including artificial promoters and transcriptional regulation to develop improved mammalian cell lines. A major focus involves using CRISPR/Cas9 technology and site-specific gene integration to construct cell libraries for discovering novel engineering targets. Additional research areas include cell line development platforms, bioprocess optimization, apoptosis and autophagy studies in production cell lines, proteomic analysis of host cell proteins, and strategies for improving difficult-to-express protein production. Analysis of Professor Lee's recent publication record reveals a strong emphasis on genome editing technologies for cell line improvement, particularly using CRISPR-based screening methods in CHO and HEK293 cells. His work bridges fundamental molecular mechanisms with practical bioprocess applications, demonstrating consistent innovation in enhancing productivity while maintaining product quality in therapeutic protein manufacturing. The research shows increasing sophistication in systems-level approaches to cell engineering. Professor Lee actively mentors researchers in the Animal Cell Engineering Lab, guiding projects that address critical challenges in biopharmaceutical production. His research is supported by various funding sources focused on advancing cell engineering technologies for therapeutic applications. The Animal Cell Engineering Lab maintains state-of-the-art facilities for mammalian cell culture, genetic engineering, and bioprocess development. The lab collaborates extensively with both academic and industry partners to translate basic research findings into practical applications for the biopharmaceutical industry, contributing significantly to advancements in therapeutic protein and viral vector manufacturing.

Byung-Kwan Choمشاهده پروفایل

استاد

• Synthetic Biology
• Systems Biology
• Microbial Genomics
• +۶ مورد دیگر

Byung-Kwan Cho is an Endowed Professor at the Korea Advanced Institute of Science and Technology (KAIST), where he leads the Systems and Synthetic Biology Laboratory in the Department of Biological Sciences. He holds a Ph.D. in Biochemical Engineering from Seoul National University and directs a research team of approximately 25 members, including postdoctoral scholars, graduate students, and researchers. Research Focus His laboratory pioneers interdisciplinary work in microbial systems and synthetic biology, with emphasis on: Designing minimal genomes for microbial cell factories Engineering acetogenic bacteria for C1 gas conversion Developing therapeutic gut microbes for metabolic diseases Synthesizing actinomycete genomes for antibiotic production Advancing enzymatic DNA synthesis for artificial genomes Achievements CJ Special Academic Award (2025) for contributions to synthetic biology The lab has produced ~200 publications, secured multiple patents, executed technology transfers, and presented at international conferences. Research is supported by industrial collaborations focusing on biomanufacturing and medical applications.